Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
88
-
Total shares
-
14.8M
-
Shares change
-
+2.56M
-
Total reported value, excl. options
-
$124M
-
Value change
-
+$15M
-
Put/Call ratio
-
0.89
-
Number of buys
-
53
-
Number of sells
-
-36
-
Price
-
$8.39
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q3 2015
96 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q3 2015.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.8M shares
.
Largest 10 shareholders include venBio Select Advisor LLC (2.15M shares), Cormorant Asset Management, LLC (2.1M shares), Wildcat Capital Management, LLC (1.71M shares), VANGUARD GROUP INC (793K shares), BlackRock Fund Advisors (747K shares), NUMERIC INVESTORS LLC (665K shares), BlackRock Institutional Trust Company, N.A. (607K shares), STATE STREET CORP (425K shares), BANK OF AMERICA CORP /DE/ (379K shares), and Aisling Capital LLC (354K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.